Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Division of Infectious Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
mBio. 2017 Nov 28;8(6):e01902-17. doi: 10.1128/mBio.01902-17.
Human gut species produce different types of toxins that antagonize closely related members of the gut microbiota. Some are toxic effectors delivered by type VI secretion systems, and others are non-contact-dependent secreted antimicrobial proteins. Many strains of secrete antimicrobial molecules, but only one of these toxins has been described to date ( secreted antimicrobial protein 1 [BSAP-1]). In this study, we describe a novel secreted protein produced by strain 638R that mediated intraspecies antagonism. Using transposon mutagenesis and deletion mutation, we identified a gene encoding a eukaryotic-like ubiquitin protein (BfUbb) necessary for toxin activity against a subset of strains. The addition of into a heterologous background strain conferred toxic activity on that strain. We found this gene to be one of the most highly expressed in the genome. The mature protein is 84% similar to human ubiquitin but has an N-terminal signal peptidase I (SpI) signal sequence and is secreted extracellularly. We found that the mature 76-amino-acid synthetic protein has very potent activity, confirming that BfUbb mediates the activity. Analyses of human gut metagenomic data sets revealed that is present in 12% of the metagenomes that have evidence of As 638R produces both BSAP-1 and BfUbb, we performed a comprehensive analysis of the toxin activity of BSAP-1 and BfUbb against a set of 40 strains, revealing that 75% of strains are targeted by one or the other of these two secreted proteins of strain 638R. We are just beginning to understand some of the important interactions that occur between microbes of the human gut microbiota that dictate the composition and abundance of its constituent members. The ability of one member to produce molecules that directly kill a coresident member has been shown among minor gut species and is just starting to be studied in the abundant species. Here, we show that some strains of have acquired a gene encoding a secreted eukaryotic-like ubiquitin protein with potent inhibitory activity against other stains. This is the first bacterially encoded ubiquitin-like molecule shown to function like a bacterial toxin. This molecule is an example of a gut symbiont acquiring and adapting a eukaryotic molecule likely to increase its competitiveness in the mammalian gut. Understanding antagonistic factors produced by abundant gut symbionts is an important prerequisite to properly engineer strains to colonize the gut for health benefits.
人类肠道物种产生不同类型的毒素,这些毒素拮抗肠道微生物群中密切相关的成员。有些是通过 VI 型分泌系统传递的毒性效应物,而另一些则是非接触依赖性分泌的抗菌蛋白。许多 菌株分泌抗菌分子,但迄今为止只描述了其中一种毒素(分泌抗菌蛋白 1 [BSAP-1])。在这项研究中,我们描述了一种由 菌株 638R 产生的新型分泌蛋白,该蛋白介导种内拮抗作用。使用转座子诱变和缺失突变,我们鉴定出一个编码真核样泛素蛋白(BfUbb)的基因,该基因对一组 菌株的毒素活性是必需的。将 加入到异源背景菌株中,赋予该菌株毒性活性。我们发现该基因在 基因组中表达水平最高。成熟蛋白与人类泛素相似性高达 84%,但具有 N 端信号肽酶 I(SpI)信号序列,可分泌到细胞外。我们发现成熟的 76 个氨基酸合成蛋白具有很强的活性,证实 BfUbb 介导了这种活性。分析人类肠道宏基因组数据集显示,在有 As 638R 产生 BSAP-1 和 BfUbb 的证据的 12%的宏基因组中存在 ,因此我们对这两种 638R 菌株分泌蛋白对一组 40 株 菌株的毒素活性进行了全面分析,结果表明这两种分泌蛋白中的一种或另一种靶向 75%的 菌株。我们才刚刚开始了解发生在人类肠道微生物群中微生物之间的一些重要相互作用,这些相互作用决定了其组成成员的组成和丰度。已经证明,少数肠道物种的一种成员能够产生直接杀死居住成员的分子,并且这种现象才刚刚开始在丰富的 物种中进行研究。在这里,我们表明,一些 菌株获得了一个编码分泌的真核样泛素蛋白的基因,该蛋白对其他 菌株具有很强的抑制活性。这是第一个被证明具有细菌毒素功能的细菌编码泛素样分子。这种分子是肠道共生菌获得和适应真核分子的一个例子,可能会增加其在哺乳动物肠道中的竞争力。了解丰富的肠道共生菌产生的拮抗因子是正确设计用于定植肠道以获得健康益处的菌株的重要前提。